Nutrient therapy for immuno-compromised patients

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 38/44 (2006.01) A01N 37/12 (2006.01) A61K 45/06 (2006.01)

Patent

CA 2457624

A nutritional supplement is taught for treating chronic debilitating diseases such as HIV/AIDS to overcome conditions of oxidative stress, decreased lean muscle mass, decreased energy production (mitochondrial failure) and support immune function. It comprises orally administrable superoxide dismutase (SOD), preferably SOD/GLIADIN, in combination with other antioxidant/immune support components (Beta Glucans, Nucleotides, Fruit Polyphenols); High Immunoglobin Whey; (undenatured whey), Ornithine alpha ketoglutarate (OKG), Branched Chain Amino Acids and Glutamine to reduce loss of lean muscle mass; and Coenzyme Q10, D-Ribose and L-Carnitine to provide energy support (decrease mitochondrial failure).

L'invention concerne un additif nutritionnel permettant de traiter des maladies débilitantes chroniques, telles que le VIH/SIDA, de manière à maîtriser des états de stress oxydatif, de masse musculaire maigre réduite, de production d'énergie réduite (défaillance mitochondriale) et de soutenir la fonction immunitaire. Cet additif comprend une superoxyde dismutase (SOD) pouvant être administrée oralement, de préférence SOD/GLIADIN, en combinaison avec d'autres composants de soutien antioxydants/immunitaires (des bêta-glucanes, des nucléotides, des polyphénoles de fruit); du lactosérum à immunoglobine élevée; (lactosérum non dénaturé), de l'alpha cétoglutarate d'ornithine (OKG), des amino acides à chaînes ramifiées et de la glutamine permettant de réduire une perte de la masse musculaire maigre; ainsi que de la Coenzyme Q10, du D-Ribose et de la L-Carnitine permettant d'apporter un soutien d'énergie (réduction de défaillance mitochondriale).

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Nutrient therapy for immuno-compromised patients does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Nutrient therapy for immuno-compromised patients, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Nutrient therapy for immuno-compromised patients will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1619437

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.